血清药物水平和心力衰竭中的药物坚持:一个比较的队列分析
Libor Jelinek1, Martin Modrak2, Jan Vaclavik3
1Department of Exercise Medicine and Cardiovascular Rehabilitation, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
概括
用血清药物水平评估心力衰竭患者的药物坚持. 虽然大多数患者坚持,但2020年的队列与2018年相比,尽管心力衰竭的严重程度相似,但坚持率较低.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学 是一个学科.
- 临床医学 临床医学
背景情况:
- 药物坚持对于管理慢性心力衰竭 (HF) 至关重要.
- 像血清药物水平测试这样的直接方法提供客观的遵守评估.
- 了解随着时间的推移的坚持趋势对于患者的结果很重要.
研究的目的:
- 为了比较两个心力衰竭患者队伍的药物坚持.
- 通过使用血清药物度,评估2018年至2020年期间遵守的变化.
- 为了确定与HF患者粘附相关的因素.
主要方法:
- 使用了一个前性的单中心注册表 (LEVEL-CHF).
- 在2018年和2020年,两个稳定HF和减少喷射分数患者的队列被录取.
- 血清药物水平用于直接粘附检测.
主要成果:
- 81%的患者完全遵守;19%的患者表现出不同程度的不遵守.
- 2020年队列的药物坚持明显低于2018年的队列 (P<0.01).
- 与2018年相比,在2020年观察到增加的BMI和禁食血糖.
结论:
- 大多数心力衰竭患者表现出完全服药.
- 血清药物水平测试是临床实践中有效的依从性评估工具.
- 在坚持和不坚持的HF患者之间没有发现显著的临床差异.
相关概念视频
Heart Failure Drugs: Inotropic Agents
488
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
488
Heart Failure Drugs: Diuretics
318
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
318
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
Heart Failure Drugs: β-Blockers
303
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
303
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
38
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
38
Comparing the Survival Analysis of Two or More Groups
115
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
115

